Latest News for: vrtx
Edit
Morgan Citizen
08 Jul 2026
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
Vertex Pharmaceuticals (VRTX) closed at $522.25 in the latest trading session, marking a -1.39% move from the prior day ... .
Edit
Collect 9.0% On VRTX Stock Now, And Still Keep 15% Of Upside (Insight Guru Inc)
Public Technologies 08 Jul 2026
Vertex Pharmaceuticals (VRTX) has been on a tear, recently touching the top of its 52-week range ... 9.0% annualized income on VRTX shares you already own, with 15% of upside room, by selling a covered call.
Edit
VRTX Elliott Wave Analysis: Next Bullish Targets Set at $556.9 – $646.4
Bitcoin World 07 Jul 2026
Edit
VRTX Acquisition of Crinetics Pharmaceuticals Presentation 2026 (Vertex Pharmaceuticals Incorporated)
Public Technologies 06 Jul 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132927200) .
Edit
Morgan Citizen
27 Jun 2026
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $491.34, denoting a +2.32% move from the preceding trading day ... .
Edit
Generational Group Advises Bradley Machine & Design LLC in its Sale to VRTX Industrial Corp.
Business Wire 05 May 2026
... is pleased to announce the sale of Bradley Machine & Design LLC to VRTX Industrial Corp.
Edit
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 CY2026 Sales Expectations
The Call 04 May 2026
VRTX) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.8% year on year to $2.99 billion ... Vertex Pharmaceuticals (VRTX) Q1 CY2026 Highlights. ... VRTX) develops and markets ...
Edit
Q1 26 VRTX Earnings Presentation (Vertex Pharmaceuticals Incorporated)
Public Technologies 04 May 2026
... in Vertex's annual report and subsequent quarterly reports filed with the Securities and Exchange Commission at https.//www.sec.gov and available through the company's website at https.//www.vrtx.com.
Edit
Vertex Pharmaceuticals (VRTX) Q1 Earnings: What To Expect
The Call 03 May 2026
Biotech company Vertex Pharmaceuticals (NASDAQ. VRTX) will be reporting results this Monday after the bell. Here’s what investors should know ... Vertex Pharmaceuticals has missed Wall Street’s revenue estimates multiple times over the last two years ... .
- 1